Home › Coronary Artery Disease › Nebraska › Omaha
Coronary Artery Disease clinical trials in Omaha, NE
5 studies for Coronary Artery Disease are looking for participants at sites in and around Omaha (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
RecruitingPhase 4
- Methodist Physicians Clinic Heart Consultants, Omaha
Product Surveillance Registry
RecruitingObservational study
- Omaha, Omaha
Randomization of Single vs Multiple Arterial Grafts
Recruiting
- University of Nebraska Medical Center, Omaha
Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women
Recruiting
- Methodist Physicians Health, Omaha
- University of Nebraska Medical Center, Omaha
Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes
RecruitingPhase 4
- Omaha VA Nebraska-Western Iowa Health Care System, Omaha, NE, Omaha
About Coronary Artery Disease
Coronary artery disease (CAD) is the most common type of heart disease. It can lead to angina and heart attack. Read about symptoms and tests.
More about Coronary Artery Disease on MedlinePlus
Coronary Artery Disease trials in other cities
- New York City, NY20 studies
- Dallas, TX16 studies
- Boston, MA16 studies
- Atlanta, GA16 studies
- Minneapolis, MN15 studies
- Jacksonville, FL12 studies
- Cleveland, OH12 studies
- Nashville, TN11 studies
- Durham, NC9 studies
- Columbus, OH9 studies
- Plano, TX9 studies
- Philadelphia, PA9 studies
Other studies in Omaha
- Prostate Cancer29 studies
- Non-Small Cell Lung Cancer25 studies
- Breast Cancer23 studies
- Cancer (all types)19 studies
- Colorectal Cancer18 studies
- Multiple Myeloma17 studies
- Ovarian Cancer15 studies
- Pancreatic Cancer15 studies
- Head and Neck Squamous Cell Carcinoma15 studies
- Metastatic Cancer14 studies
- Non-Hodgkin Lymphoma14 studies
- Lung Cancer13 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.